ClinicalTrials.gov
public full text
Public Domain
Pharmacogenetics in Non Small Cell Lung Cancer
Study the effect of genetic polymorphism in the membrane copper transporter 1 protein \[CTR1; encoded by the solute carrier family 31 member 1 gene (SLC31A1 gene)\] and its genetic expression levels on the clinical outcome of cisplatin-based regimen used in the treatment of Non-Small Cell Lung Cancer (NSCLC) in terms of : * Treatment response : partial response (PR) / complete response (CR) and Progression-free survival (PFS) * Treatment resistance : stationary disease (SD) or progressed disease * Frequency and severity of regimen related toxicity
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Clinical Trial Of Neoadjuvant Chemotherapy (NAC)In Upper Tract Urothelial Carcinoma (UTUC)#847544
- Safety Study of SLC-0111 in Subjects With Advanced Solid Tumours#1149994
- A Safety and Tolerability Study of NC318 in Combination With Chemotherapy for Subjects With Advanced or Metastatic NSCLC#426792
- Gefitinib Combined With Thalidomide to Treat NSCLC#1128252
- PET Imaging With Tc-94m Sestamibi to Assess Resistance to Chemotherapy#1369376
Record · ID 1418738
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive